These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. The biotechnology-value chain: development of Sm14 as a schistosomiasis vaccine. Tendler M; Simpson AJ Acta Trop; 2008; 108(2-3):263-6. PubMed ID: 18834847 [TBL] [Abstract][Full Text] [Related]
34. The four things a service business must get right. Frei FX Harv Bus Rev; 2008 Apr; 86(4):70-80, 136. PubMed ID: 18435008 [TBL] [Abstract][Full Text] [Related]
35. Strategies to fight low-cost rivals. Kumar N Harv Bus Rev; 2006 Dec; 84(12):104-12, 163. PubMed ID: 17183797 [TBL] [Abstract][Full Text] [Related]
36. Promoting, improving and accelerating the drug development and approval processes. Graul AI Drug News Perspect; 2009; 22(1):30-8. PubMed ID: 19209297 [TBL] [Abstract][Full Text] [Related]
37. American Society of Clinical Oncology guidance statement: the cost of cancer care. Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE; J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533 [TBL] [Abstract][Full Text] [Related]
38. Brazil: An emerging partner in drug R&D. Rodrigues DG IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884 [TBL] [Abstract][Full Text] [Related]
39. Human due diligence. Harding D; Rouse T Harv Bus Rev; 2007 Apr; 85(4):124-31, 142. PubMed ID: 17432159 [TBL] [Abstract][Full Text] [Related]
40. The experience trap. Sengupta K; Abdel-Hamid TK; Van Wassenhove LN Harv Bus Rev; 2008 Feb; 86(2):94-101, 137. PubMed ID: 18314637 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]